All Communications

News

| 12.01.2021

New Junior Research Group on Lassa Fever

Till Omansen receives coveted Leibniz funding

The Bernhard Nocht Institute for Tropical Medicine (BNITM) gets the opportunity to establish another junior research group. Dr. Till Omansen from the Department of Clinical Research has been awarded funding from the Leibniz funding programme to establish an independent Junior Research Group. The aim is to research the pathophysiology of Lassa fever. The new transnational group will be based in both the Clinical Research Department and the Virology Department of the BNITM.

[more]

News

| 23.12.2020

Child-friendly antimalarial drugs are effective and better tolerated

Artemisinin-based combination therapy

Are child-friendly, easily soluble tablets or child syrups as effective, safe and tolerable as conventional tablets for malaria therapy? This question was investigated by the Clinical Research Department at the Bernhard Nocht Institute for Tropical Medicine (BNITM) in an elaborate, systematic analysis of available study data, which was published in the Cochrane database this month.

[more]

News

|

New ANTICOV study platform for African doctors

Largest clinical trial for treatment of COVID-19 cases in Africa begins

Hamburg/Kumasi. Thirteen African countries and an international network of research institutions have jointly established a study platform to be able to conduct clinical trials for early treatment of COVID-19 disease. The Kumasi Centre for Collaborative Research (KCCR) in Ghana is also participating in the trial in cooperation with the Bernhard Nocht Institute for Tropical Medicine (BNITM).

[more]

News

|

Transport patients with infectious diseases - but safely!

TROPICSAFE e-learning platform launched for the safe use of personal protective equipment for infectious diseases

How can healthcare professionals safely transport people with infectious diseases such as COVID-19 or highly pathogenic pathogens such as Ebola? What do you have to consider when handling personal protective equipment (PPE)? This can now be learned on the freely available electronic training platform TROPICSAFE.

[more]

Pressemitteilung

| 02.11.2020

Doppelte BMBF-Förderung für virologische Infektionsforschung in Hamburg

Vier Millionen Euro für neue Nachwuchsgruppen am BNITM

Hamburg. Zwei Forschende des Bernhard-Nocht-Instituts für Tropenmedizin (BNITM), die Nachwuchswissenschaftlerin Dr. Maria Rosenthal und der Nachwuchswissenschaftler Dr. Renke Lühken, haben jeweils rund zwei Millionen Euro für ihre innovativen Forschungsansätze im Bereich der Prävention und Therapie neu auftretender Infektionskrankheiten eingeworben. Rosenthal aus der Abteilung Virologie sowie Lühken aus der Abteilung Arbovirologie werden ab sofort ihre eigenen Arbeitsgruppen aufbauen, um in den nächsten fünf Jahren die bewilligten Projekte zu realisieren. Gefördert werden beide durch das Bundesministerium für Bildung und Forschung (BMBF).

[more]

Research Highlight

|

Key protein of the malaria pathogen identified and the burden of disease in loiasis determined: Paul-Christian Burda and Luzia Veletzky publish important BNITM research results

A research team of the Bernhard Nocht Institute for Tropical Medicine (BNITM) has identified a protein of the malaria parasite Plasmodium falciparum, which plays an important role in the growth of the pathogen in red blood cells. Another team from the BNITM has proven that infections with the African eye worm Loa loa cause significantly more adverse effects than previously thought. The results were published in the journals Cell Reports and The Lancet Infectious Diseases.

[more]

Pressemitteilung

|

Mobile laboratory expands testing capacity and treatment options on Lesbos

Kopenhagen / Hamburg / Kara Tepe – The mobile laboratory of the Bernhard Nocht Institute for Tropical Medicine (BNITM) is now ready for use in the newly built refugee camp in Kara Tepe on the island of Lesbos, Greece. The mobile laboratory was sent at the request of the Greek authorities as part of the World Health Organization (WHO) Global Outbreak Alert and Response Network (GOARN) with financial support from the WHO Regional Office for Europe.

[more]

Pressemitteilung

| 01.10.2020

120 Jahre Forschung für Globale Gesundheit

Bernhard-Nocht-Institut für Tropenmedizin begeht virtuelles Jubiläum

Hamburg. Ein Jubiläum inmitten einer Pandemie: Auch für das Bernhard-Nocht-Institut für Tropenmedizin (BNITM) sind es bewegte Zeiten. Wegen der Ausbreitung des SARS-CoV-2-Virus unterliegt auch das BNITM vielen Einschränkungen, und geplante Feierlichkeiten mussten abgesagt werden. Dennoch blicken die Mitarbeiterinnen und Mitarbeiter gemeinsam zurück – vor allem aber nach vorn.

[more]

News

| 31.08.2020

It is about more than just antibody levels

Ebola vaccination provides less protection than surviving Ebola disease

The number of Ebola-specific antibodies in the blood is as high after an Ebola vaccination as after a natural infection. However, these antibodies provide less protection against re-infection than antibodies from Ebola survivors. These new research results were recently published in the journal Viruses by the research group of Prof. César Muñoz-Fontela of the Bernhard Nocht Institute for Tropical Medicine (BNITM).

[more]

News

| 25.08.2020

Stellungnahme zu Äußerungen von PD Dr. med. Norbert Schwarz

Das Bernhard-Nocht-Institut für Tropenmedizin (BNITM) widmet sich intensiv der Eindämmung der COVID-19-Pandemie. Den Herausforderungen der momentanen Situation begegnet das BNITM auf Grundlage von gesicherten wissenschaftlichen Erkenntnissen. In der folgenden Stellungnahme distanziert sich der Vorstand des BNITM ausdrücklich von den Aussagen des Mitarbeiters PD Dr. med. Norbert Schwarz, die er in einem Interview getätigt hat.

[more]
Displaying results 11 to 20 out of 288
Logo Mitglied der Leibniz Gemeinschaft